Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT06710210
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT06710210
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT06710210. Randomized; single masking; primary purpose treatment. Start 2026-04-01 (actual); primary completion 2028-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease
- Acronym
- BIOHYBRID
- Condition
- Coronary Artery Disease
- Condition
- Diffuse Coronary Artery Disease
- Intervention (Device)
- PCI with a bioresorbable scaffold and drug-coated balloon(s)
- Intervention (Device)
- PCI with drug-eluting stent(s)
- Lead sponsor
- University Hospital, Geneva
- Collaborator
- Clinical Trials Unit Bern (CTU)
Record details
- Record id
cardio:ct-nct06710210- Content hash
d4f0861b41093e4dc5af933008efb43dac87f11ad9df2bbeb35f2dc9b9ef0cd2